IDEAYA Ahead of Pivotal Readout - Asymmetric Long Trade into Binary Catalyst
IDEAYA (IDYA) is trading near $31 with a pivotal clinical readout imminent. The company has solid cash runway, a focused oncology franchise, and favorable analyst sentiment following recent Phase 2 data. This trade targets an asymmetric mid-term upside into the catalyst while keeping risk defined with a tight stop.